#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Blastic plasmacytoid dendritic cell neoplasia Acute lymphocytic leukaemia Philadelphia positive chronic myeloid leukaemia Hepatocellular carcinoma Extranodal marginal zone B-cell lymphoma (MALT type) Juvenile chronic myelomonocytic leukaemia Pleomorphic liposarcoma Conjunctivitis allergic Hyperchylomicronaemia Cognitive disorder Lupus nephritis Superficial vein thrombosis Lip and/or oral cavity cancer Choroid melanoma Pleural mesothelioma More trials…

    Learn about Rare Diseases

    Alagille syndrome Usher’s syndrome – Treatment Alternating hemiplegia of childhood – Diagnostics Turner’s syndrome – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Mantle cell lymphoma refractory – Diagnostics KBG syndrome – Treatment Mucopolysaccharidosis I – Basic Information Mucopolysaccharidosis II – Trials in Disease Ewing’s sarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ILOPROST Lisocabtagene Maraleucel Gliquidone Anselamimab Thiamine Nitrate Fludeoxyglucose (18F) RPTR-1-201 ZOREVUNERSEN SODIUM Raxtozinameran Quemliclustat Anhydrous Cyclophosphamide Clonazepam Camphor Levoleucovorin 19Cp02 Air, Medicinal Acalabrutinib Futibatinib Mitomycin Roxadustat More therapies…

    Learn about Your Condition

    Mite allergy Chordoma Constipation Ataxia telangiectasia Precocious puberty Haemofiltration Retinoblastoma Gastrectomy Prodromal Alzheimer's disease Acute cardiac event Portal hypertension Nephrogenic anaemia Anal fissure Conjunctivitis Subdural haematoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Tinzaparin Sodium to Prevent Venous Thromboembolism in Adults with Liver Cirrhosis and Hepatocellular Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Tinzaparin Sodium
    Italy

  • Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Obesity
    • Overweight
    Bulgaria Czechia Denmark France Germany Greece +4

  • A Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Inebilizumab
    Belgium Bulgaria Czechia France Germany Greece +6

  • A Randomized Trial of lu af28996 dh1 to Reduce Motor Fluctuations in Adults with Parkinson’s Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Czechia France Germany Italy Poland Spain +1

  • Efficacy and safety of oral venglustat versus intravenous imiglucerase in children aged 2‑11 years with Gaucher disease type 3

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Gaucher’s disease type III
    Investigated Drugs:
    • Imiglucerase
    • Venglustat
    Finland France Germany Hungary Italy Spain

  • Efficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing’s syndrome

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cushing’s syndrome
    Investigated Drugs:
    • Glucose
    • Osilodrostat
    • Dexamethasone
    Bulgaria France Germany Italy Poland Romania +1

  • Safety and tolerability study of S-241656 with posaconazole in patients with AML, MDS/AML or CMML

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • S-241656
    • Posaconazole
    Finland France Germany Italy The Netherlands Spain

  • Efficacy of bupivacaine hydrochloride and lidocaine hydrochloride compared with amiodarone hydrochloride as first‑line treatment for electrical storm in patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amiodarone Hydrochloride
    • Bupivacaine Hydrochloride
    • Lidocaine Hydrochloride Monohydrate
    Italy

  • A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hereditary haemorrhagic telangiectasia
    Belgium Bulgaria France Germany Hungary Italy +3

  • Phase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Thalassaemia
    • Thalassaemia alpha
    • Thalassaemia beta
    Investigated Drugs:
    • Mitapivat
    Greece Italy
Previous Page
1 … 17 18 19 20 21 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!